{"id":"https://openalex.org/W2001998392","doi":"https://doi.org/10.1016/s0960-894x(01)00008-7","title":"New 5-HT1A receptor agonists possessing 1,4-Benzoxazepine scaffold exhibit highly potent anti-ischemic effects","display_name":"New 5-HT1A receptor agonists possessing 1,4-Benzoxazepine scaffold exhibit highly potent anti-ischemic effects","publication_year":2001,"publication_date":"2001-02-01","ids":{"openalex":"https://openalex.org/W2001998392","doi":"https://doi.org/10.1016/s0960-894x(01)00008-7","mag":"2001998392","pmid":"https://pubmed.ncbi.nlm.nih.gov/11229779"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(01)00008-7","doi":"https://doi.org/10.1016/s0960-894x(01)00008-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(01)00008-7","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109350740","display_name":"Katsuhide Kamei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Katsuhide Kamei","raw_affiliation_strings":["Suntory Biomedical Research Limited, Osaka, Japan. katsuhide_kamei@suntory.co.jp","Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Biomedical Research Limited, Osaka, Japan. katsuhide_kamei@suntory.co.jp","institution_ids":["https://openalex.org/I4210122276"]},{"raw_affiliation_string":"Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113823297","display_name":"Noriko Maeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Maeda","raw_affiliation_strings":["Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111551033","display_name":"Ryoko Ogino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryoko Ogino","raw_affiliation_strings":["Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008047873","display_name":"Makoto Koyama","orcid":"https://orcid.org/0000-0003-3997-8244","observed_orcids":["https://orcid.org/0000-0003-3997-8244"]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Koyama","raw_affiliation_strings":["Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071614312","display_name":"Mika Nakajima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mika Nakajima","raw_affiliation_strings":["Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037997380","display_name":"Toshio Tatsuoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshio Tatsuoka","raw_affiliation_strings":["Suntory Limited, Mori Bldg. No. 31, 5-7-2, Kojimachi, Chiyoda-ku, Tokyo 102-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Limited, Mori Bldg. No. 31, 5-7-2, Kojimachi, Chiyoda-ku, Tokyo 102-8530, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103416706","display_name":"Tomochika Ohno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122276","display_name":"Suntory (Japan)","ror":"https://ror.org/02jg1fa85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210122276"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomochika Ohno","raw_affiliation_strings":["Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Biomedical Research Limited, 1-1-1, Wakayama-dai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan","institution_ids":["https://openalex.org/I4210122276"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104622442","display_name":"Teruyoshi Inoue","orcid":"https://orcid.org/0000-0002-1785-6062","observed_orcids":["https://orcid.org/0000-0002-1785-6062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teruyoshi Inoue","raw_affiliation_strings":["Suntory Limited, Mori Bldg. No. 31, 5-7-2, Kojimachi, Chiyoda-ku, Tokyo 102-8530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suntory Limited, Mori Bldg. No. 31, 5-7-2, Kojimachi, Chiyoda-ku, Tokyo 102-8530, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109350740"],"corresponding_institution_ids":["https://openalex.org/I4210122276"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.576,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.88149951,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"11","issue":"4","first_page":"595","last_page":"598"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.37700000405311584,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.37700000405311584,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.31130000948905945,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13876","display_name":"Chemical synthesis and pharmacological studies","score":0.1679999977350235,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonist","display_name":"5-HT1A receptor agonist","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-ischemic-effect","display_name":"anti-ischemic effect","score":0.8230000138282776},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9620000123977661},{"id":"https://openalex.org/keywords/transient-middle-cerebral-artery-occlusion","display_name":"transient middle cerebral artery occlusion","score":0.9670000076293945}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9168299436569214},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.7460631132125854},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.6029199361801147},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.5739622116088867},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5284428596496582},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5243882536888123},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.47872185707092285},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4513775110244751},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.44337424635887146},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3785158693790436},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.24915564060211182},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20445141196250916},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.05832338333129883},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001831","descriptor_name":"Body Temperature","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D044263","descriptor_name":"Receptors, Serotonin, 5-HT1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0960-894x(01)00008-7","doi":"https://doi.org/10.1016/s0960-894x(01)00008-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(01)00008-7","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:11229779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11229779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1772950163","https://openalex.org/W1978106541","https://openalex.org/W1994702289","https://openalex.org/W1995475376","https://openalex.org/W2002002184","https://openalex.org/W2004748949","https://openalex.org/W2014039042","https://openalex.org/W2015467493","https://openalex.org/W2022593257","https://openalex.org/W2038004358","https://openalex.org/W2043750066","https://openalex.org/W2049036332","https://openalex.org/W2056445339","https://openalex.org/W2075786626","https://openalex.org/W2077760177","https://openalex.org/W2093421851","https://openalex.org/W2128089457","https://openalex.org/W2160869575","https://openalex.org/W2262157964","https://openalex.org/W3214999599","https://openalex.org/W4242666285","https://openalex.org/W4248755574"],"related_works":["https://openalex.org/W2056395878","https://openalex.org/W2181071897","https://openalex.org/W2051844708","https://openalex.org/W2949513317","https://openalex.org/W2520316684","https://openalex.org/W2122844678","https://openalex.org/W2094007051","https://openalex.org/W2042658986","https://openalex.org/W2405415916","https://openalex.org/W2141142101"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}